# Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy

> **NCT02522598** · PHASE2 · COMPLETED · sponsor: **Vivozon, Inc.** · enrollment: 38 (actual)

## Conditions studied

- Post-Operative Pain

## Interventions

- **DRUG:** VVZ-149 injections
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02522598
- **Lead sponsor:** Vivozon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2016-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02522598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02522598, "Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02522598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*